Susan E. Yanni
About
In The Last Decade
Susan E. Yanni
13 papers receiving 536 citations
Peers
Comparison fields: 5 of 52
- Ophthalmology 357
- Radiology, Nuclear Medicine and Imaging 318
- Molecular Biology 137
- Pediatrics, Perinatology and Child Health 76
- Pulmonary and Respiratory Medicine 72
Countries citing papers authored by Susan E. Yanni
This map shows the geographic impact of Susan E. Yanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Yanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Yanni more than expected).
Fields of papers citing papers by Susan E. Yanni
This network shows the impact of papers produced by Susan E. Yanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Yanni. The network helps show where Susan E. Yanni may publish in the future.
Co-authorship network of co-authors of Susan E. Yanni
This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Yanni. A scholar is included among the top collaborators of Susan E. Yanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Yanni. Susan E. Yanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Efficacy of RTH258 (ESBA1008), an Anti-VEGF Agent, Applied by Microvolume Injection or Infusion in Subjects with Neovascular AMD | 4 |
| 2 | 27 | |
| 3 | 24 | |
| 4 | 59 | |
| 5 | Beyond Screening for Risk Factors…The Objective Detection of Strabismus and Amblyopia | 4 |
| 6 | 103 | |
| 7 | 143 | |
| 8 | The PGF2 FP Receptor Mediates Retinal Angiogenic Cell Behaviors In Vitro | 1 |
| 9 | 47 | |
| 10 | 49 | |
| 11 | 28 | |
| 12 | 64 | |
| 13 | PGE2 Receptor EP4 Is a Potential Therapeutic Target for the Treatment of Pathological Ocular Angiogenesis | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.